Europe
RedHill Biopharma, with offices in Tel Aviv, Israel and Raleigh, North Carolina, announced positive topline data from its first Phase III trial of RHB-104 for Crohn’s disease. It met all primary endpoint and key secondary endpoints.
BioLineRx, based in Tel Aviv, Israel, and Merck & Co, based in Kenilworth, New Jersey, announced they are expanding their immuno-oncology collaboration.
Transition continues as biotech companies continue to adjust their leadership ranks and strengthen the members of their organization representing and overseeing the companies. Here is a look at some of those transitions.
Genentech and Horizon Pharma were the only two biopharma companies that made People’s 2018 list of “50 Companies That Care,” a list that highlights how a company makes a difference in the lives of its employees, as well as the communities those companies call home.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Forty years ago, Louise Brown was born on July 25. She was the first so-called “test tube baby,” born through in vitro fertilization (IVF).
Shares of Nabriva Therapeutics are rising this morning after the company announced it acquired privately-held Zavante Therapeutics.
Dutch researchers have halted a clinical trial testing the use of Pfizer’s erectile dysfunction drug Viagra in women following the death of 11 babies. The drug was being used to see if it would help boost the growth of a baby while it was still in the womb.
Despite positive Phase III clinical trial data for Allergan’s age-related macular degeneration drug, investors weren’t as positive about it.
Shares of France’s TxCell S.A. have skyrocketed about 150 percent this morning after Sangamo Therapeutics announced it was acquiring a majority stake in the company for €72 million (about $82 million) in a cash deal.
PRESS RELEASES